PEGANONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Peganone, and what generic alternatives are available?
Peganone is a drug marketed by Recordati Rare and is included in one NDA.
The generic ingredient in PEGANONE is ethotoin. There is one drug master file entry for this compound. Additional details are available on the ethotoin profile page.
Summary for PEGANONE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 44 |
Patent Applications: | 2,550 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for PEGANONE |
What excipients (inactive ingredients) are in PEGANONE? | PEGANONE excipients list |
DailyMed Link: | PEGANONE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PEGANONE
US Patents and Regulatory Information for PEGANONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Recordati Rare | PEGANONE | ethotoin | TABLET;ORAL | 010841-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Recordati Rare | PEGANONE | ethotoin | TABLET;ORAL | 010841-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |